MX375503B - Metodos para predecir riesgo de neumonia intersticial. - Google Patents
Metodos para predecir riesgo de neumonia intersticial.Info
- Publication number
- MX375503B MX375503B MX2015010406A MX2015010406A MX375503B MX 375503 B MX375503 B MX 375503B MX 2015010406 A MX2015010406 A MX 2015010406A MX 2015010406 A MX2015010406 A MX 2015010406A MX 375503 B MX375503 B MX 375503B
- Authority
- MX
- Mexico
- Prior art keywords
- interstitial pneumonia
- methods
- predicting
- risk
- identification
- Prior art date
Links
- 208000029523 Interstitial Lung disease Diseases 0.000 title abstract 3
- 239000000090 biomarker Substances 0.000 abstract 1
- 208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361764986P | 2013-02-14 | 2013-02-14 | |
| PCT/US2014/016601 WO2014127290A2 (en) | 2013-02-14 | 2014-02-14 | Methods for predicting risk of interstitial pneumonia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015010406A MX2015010406A (es) | 2016-04-04 |
| MX375503B true MX375503B (es) | 2025-03-06 |
Family
ID=51354692
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015010406A MX375503B (es) | 2013-02-14 | 2014-02-14 | Metodos para predecir riesgo de neumonia intersticial. |
| MX2020010147A MX2020010147A (es) | 2013-02-14 | 2015-08-12 | Metodos para predecir el riesgo de neumonia intersticial. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020010147A MX2020010147A (es) | 2013-02-14 | 2015-08-12 | Metodos para predecir el riesgo de neumonia intersticial. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10752952B2 (enExample) |
| EP (3) | EP4039821A3 (enExample) |
| JP (1) | JP6530717B2 (enExample) |
| KR (5) | KR102398430B1 (enExample) |
| CN (1) | CN105143467B (enExample) |
| CA (2) | CA2900073C (enExample) |
| HK (1) | HK1219115A1 (enExample) |
| MX (2) | MX375503B (enExample) |
| RU (1) | RU2670148C2 (enExample) |
| WO (1) | WO2014127290A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014127290A2 (en) | 2013-02-14 | 2014-08-21 | The Regents Of The University Of Colorado | Methods for predicting risk of interstitial pneumonia |
| CN106538029B (zh) | 2014-06-27 | 2020-10-16 | 泰科弗勒克斯公司 | 用于发送数据单元的方法和装置 |
| WO2017066712A2 (en) | 2015-10-16 | 2017-04-20 | The Children's Medical Center Corporation | Modulators of telomere disease |
| WO2017066796A2 (en) * | 2015-10-16 | 2017-04-20 | The Children's Medical Center Corporation | Modulators of telomere disease |
| WO2017121769A1 (en) * | 2016-01-12 | 2017-07-20 | bioMérieux | In vitro method for predicting a risk of developing pneumonia in a subject |
| WO2019005847A1 (en) | 2017-06-26 | 2019-01-03 | The Regents Of The University Of Colorado, A Body Corporate | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF FIBROTIC PULMONARY DISEASE |
| US11713487B2 (en) | 2017-07-14 | 2023-08-01 | The Regents Of The University Of California | Methods of predicting transplant rejection risk |
| CN107677835B (zh) * | 2017-09-26 | 2019-08-09 | 上海市肺科医院 | 一种ae-ipf的蛋白标记物及其应用 |
| US12351874B2 (en) | 2018-03-12 | 2025-07-08 | The Regents Of The University Of California | Assessing transplant rejection status by analysis of t-cell receptor subunit repertoire diversity |
| CA3101527A1 (en) * | 2018-06-06 | 2019-12-12 | Lexent Bio, Inc. | Methods for fingerprinting of biological samples |
| CN108660206B (zh) * | 2018-08-14 | 2022-11-22 | 天佳吉瑞基因科技有限公司 | 预测或辅助预测肺部辐射后患放射性肺炎风险的遗传生物标记物及其应用 |
| CN110184355A (zh) * | 2019-06-06 | 2019-08-30 | 四川大学华西第二医院 | 一种与宫颈鳞癌发生发展相关的生物标志物及其应用 |
| JP7300642B2 (ja) * | 2019-06-14 | 2023-06-30 | 国立大学法人浜松医科大学 | 特発性肺線維症の予後予測方法 |
| RU2720713C9 (ru) * | 2020-03-27 | 2020-05-18 | Евгений Олегович Рубальский | Набор синтетических олигонуклеотидов для выявления рнк коронавируса |
| RU2732608C1 (ru) * | 2020-04-09 | 2020-09-21 | Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации | Набор реагентов для выявления РНК вируса SARS-CoV-2, возбудителя нового коронавирусного заболевания COVID-2019, методом обратной транскрипции-полимеразной цепной реакции в реальном времени |
| RU2727054C1 (ru) * | 2020-04-24 | 2020-07-17 | Сергей Феликсович Дрозд | Способ выявления кДНК коронавируса SARS-CoV-2 с помощью синтетических олигонуклеотидных праймеров в полимеразной цепной реакции |
| JP7570088B2 (ja) * | 2020-06-18 | 2024-10-21 | 国立研究開発法人産業技術総合研究所 | 情報処理システム、情報処理方法、同定方法及びプログラム |
| DE102020005556B4 (de) | 2020-09-02 | 2023-07-06 | Gesellschaft für Individualisierte Medizin mbH | Verfahren zur Prognose der Schwere des Verlaufs einer COVID-19-Erkrankung |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US6825047B1 (en) | 1996-04-03 | 2004-11-30 | Applera Corporation | Device and method for multiple analyte detection |
| US7235406B1 (en) | 1996-04-03 | 2007-06-26 | Applera Corporation | Nucleic acid analysis device |
| US6272939B1 (en) | 1999-10-15 | 2001-08-14 | Applera Corporation | System and method for filling a substrate with a liquid sample |
| US20020197646A1 (en) * | 2001-02-14 | 2002-12-26 | Nogee Lawrence M. | Single nucleotide polymorphisms associated with interstitial lung disease |
| US6514750B2 (en) | 2001-07-03 | 2003-02-04 | Pe Corporation (Ny) | PCR sample handling device |
| CA3101636A1 (en) * | 2010-01-26 | 2011-08-04 | National Jewish Health | Diagnosis and prognosis of idiopathic interstitial pneumonia by rs35705950 snp in muc5b gene promoter |
| US20120034214A1 (en) * | 2010-07-22 | 2012-02-09 | Isis Innovation Limited | Methods and kits for determining the prognosis of pulmonary sarcoidosis |
| WO2014127290A2 (en) | 2013-02-14 | 2014-08-21 | The Regents Of The University Of Colorado | Methods for predicting risk of interstitial pneumonia |
-
2014
- 2014-02-14 WO PCT/US2014/016601 patent/WO2014127290A2/en not_active Ceased
- 2014-02-14 JP JP2015558170A patent/JP6530717B2/ja active Active
- 2014-02-14 KR KR1020217015148A patent/KR102398430B1/ko active Active
- 2014-02-14 CN CN201480018768.XA patent/CN105143467B/zh active Active
- 2014-02-14 MX MX2015010406A patent/MX375503B/es active IP Right Grant
- 2014-02-14 EP EP22159018.5A patent/EP4039821A3/en active Pending
- 2014-02-14 HK HK16107058.6A patent/HK1219115A1/zh unknown
- 2014-02-14 CA CA2900073A patent/CA2900073C/en active Active
- 2014-02-14 KR KR1020227015561A patent/KR102544414B1/ko active Active
- 2014-02-14 RU RU2015138992A patent/RU2670148C2/ru active
- 2014-02-14 KR KR1020247034107A patent/KR102768285B1/ko active Active
- 2014-02-14 EP EP14751579.5A patent/EP2956555A4/en not_active Withdrawn
- 2014-02-14 CA CA3207723A patent/CA3207723A1/en active Pending
- 2014-02-14 EP EP17169995.2A patent/EP3252169B1/en active Active
- 2014-02-14 KR KR1020157024820A patent/KR102264761B1/ko active Active
- 2014-02-14 KR KR1020237019718A patent/KR102719212B1/ko active Active
-
2015
- 2015-07-30 US US14/813,559 patent/US10752952B2/en active Active
- 2015-08-12 MX MX2020010147A patent/MX2020010147A/es unknown
-
2020
- 2020-07-14 US US16/928,436 patent/US11976328B2/en active Active
-
2024
- 2024-04-10 US US18/631,414 patent/US20240271215A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX375503B (es) | Metodos para predecir riesgo de neumonia intersticial. | |
| MA40325A (fr) | Procédés et compositions pour diagnostiquer, pronostiquer et confirmer une pré-éclampsie. | |
| CA2927824C (en) | TESTS TO DETERMINE BIOMARKERS OF A PLASMA KALLICREIN SYSTEM | |
| EP3688158A4 (en) | DEVICES, SYSTEMS AND METHODS FOR BIOMARKER ANALYSIS | |
| WO2013075055A3 (en) | Kits and methods for assessing appendicitis | |
| WO2014028884A3 (en) | Cancer diagnostics using biomarkers | |
| BR112014018995A2 (pt) | Sistemas para executar ensaio automatizado | |
| EP3283643B8 (en) | Means for diagnosing, predicting or monitoring pneumocystis pneumonia | |
| BR112014031365A2 (pt) | métodos de detectar doenças ou condições | |
| WO2013083781A3 (en) | Biomarkers and test panels useful in systemic inflammatory conditions | |
| EP3697536A4 (en) | DEVICES, SYSTEMS AND METHODS FOR HIGH RATE SINGLE CELL ANALYSIS | |
| MX2017005888A (es) | Dispositivos, sistemas y metodos para la deteccion de analitos. | |
| EP3456035A4 (en) | SYSTEMS AND METHODS FOR PROVIDING A SELF-SELECTION SERVICE | |
| EP3350980A4 (en) | SYSTEMS AND METHODS FOR ADMINISTERING, ANALYZING AND PROVIDING VISUALIZATIONS OF MULTI-PARTY IDIALOGIES | |
| NZ629555A (en) | Monocyte biomarkers for cancer detection | |
| HK1231555A1 (zh) | 生物标志物及其用途 | |
| MX388966B (es) | Metodos y sistemas para amplificacion de acido nucleico. | |
| IL250867B (en) | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm | |
| WO2013028807A3 (en) | Renal cell carcinoma biomarkers and uses thereof | |
| DK3454067T3 (da) | Forudsigende batteritest-systemer og -fremgangsmåder | |
| MX2015015452A (es) | Metodo y sistema para evaluar una condicion de salud. | |
| EP3298135C0 (en) | SYSTEMS AND METHODS FOR PREDICTING GLYCOSYLATION IN PROTEINS | |
| EP3691627A4 (en) | BIOMARKER FOR SENESCENT CELLS | |
| EP3391200A4 (en) | SYSTEMS, DEVICES AND PROCESSES FOR STEP-BY-STEP ACCESS | |
| TR201906242T4 (tr) | Elektroki̇myasal deteksi̇yon metodu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |